Expression of transforming growth factor-β1 in rat ventral prostate and dunning R3327 PAP prostate tumor after castration and estrogen treatment

Prostate

Volumn 29, Issue 4, 1996, Pages 209-218

  Lindström, Pernilla ^a   Bergh, Anders ^a   Holm, Ingvar ^a   Damber, Jan Erik ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

competitive reverse transcription polymerase chain reaction; endocrine treatment; immunohistochemistry; in situ hybridization; mRNA; prostatic adenocarcinoma

Indexed keywords

ESTROGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CASTRATION; ESTROGEN THERAPY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; RAT; REGRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; BLOTTING, NORTHERN; ESTROGENS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEOPLASMS, EXPERIMENTAL; ORCHIECTOMY; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATIC NEOPLASMS; RATS; RATS, INBRED STRAINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029951757     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199610)29:4<209::AID-PROS2>3.0.CO;2-6     Document Type: Article

References (39)

1. Walsh PC: Physiologic basis for hormonal therapy in carcinoma of the prostate. Urol Clin North Am 2:125-140, 1975.
2. Grayhack JT, Keeler TC, Kozlowski JM: Carcinoma of the prostate. Hormonal therapy. Cancer 60:589-601, 1987.
3. Isaacs JT, Coffey DS: Adaption versus selection as the mechanism responsible for the relapse of prostatic cancer to the androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res 41: 5070-5075, 1981.
4. Kyprianou N, Martikainen P, Isaacs JT: Programmed cell death of normal and malignant prostatic cells. In Voigt K-D, Knabbe C (eds): "Endocrine Dependent Tumors." New York: Raven Press, Ltd., 1991, pp 69-81.
5. Isaacs JT, Lundmo PI, Berges R, Martikainen P, Kyprianou N, English HF: Androgen regulation of programmed death of normal and malignant prostatic cells. J Androl 13:457-464, 1992.
6. Kyprianou N, Isaacs JT: Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562, 1988.
7. Kyprianou N, Isaacs JT: Expression of transforming growth factor-β in the rat ventral prostate during castration induced programmed cell death. Mol Endocrinol 3:1515-1522, 1989.
8. Kyprianou N, English HF, Isaacs JT: Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50:3748-3753, 1990.
9. Gleave ME, Hsieh J-T, Wu H-C, von Eschenbach AC, Chung LWK: Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine growth factors. Cancer Res 52:1598-1605, 1992.
10. Westin P, Bergh A, Damber J-E: Castration induces a major reduction in the number of epithelial cells in the prostate, but not in the highly differentiated Dunning R3327 PAP prostatic tumor in rats. Prostate 22:65-74, 1993.
11. Brändström A, Westin P, Bergh A, Cajander S, Damber J-E: Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat. Cancer Res 54:3594-3601, 1994.
12. Tenniswood MP, Guenette S, Lakins J, Mooibroek M, Wong P, Welsh J-E: Active cell death in hormone-dependent tissues. Cancer Metastasis Rev 11:197-220, 1992.
13. Wilding G: Response of prostate cancer cells to peptide growth factors: Transforming growth factor-β. Cancer Surv 11:147-163, 1991.
14. Wilding G, Zugmeier G, Knabbe C, Flanders K, Gelmann E: Differential effects of transforming growth factor β on human prostate cancer cells in vitro. Mol Cell Endocrinol 62:79-87, 1989.
15. Steiner MS, Barrack ER: Transforming growth factor-β1 overproduction in prostate cancer: Effects on growth in vivo and in vitro. Mol Endocrinol 6:15-25, 1992.
16. Martikainen P, Kyprianou N, Isaacs JT: Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology 127:2963-2968, 1990.
17. Steiner MS, Barrack ER: Expression of transforming growth factors (TGFα and TGFβ) and epidermal growth factor (EGF) in normal and malignant rat prostate. J Urol 143:240A, 1990.
18. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC: Association of transforming growth factor-β1 with prostate cancer: An immunohistochemical study. Hum Pathol 24:4-9, 1993.
19. Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL, Rowley DA: A highly immunogenic tumor transfected with a murine transforming growth factor type β1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 87:1486-1490, 1990.
20. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS: Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171, 1986.
21. Welch DR, Farba A, Nakajima M: Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87:7678-7682, 1990.
22. Landström M, Bergh A, Tomic R, Damber J-E: Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma. Prostate 17:57-68, 1990.
23. Westin P, Brändström A, Damber J-E, Bergh A: Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma. Br J Cancer 72:140-145, 1995.
24. Landström M, Damber J-E, Berg A, Tomic R: Dose/response study of the effects of oestrogens on tumor growth and morphology in Dunning R3327 prostatic adenocarcinoma. J Cancer Res Clin Oncol 118:30-34, 1992.
25. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
26. Derynck R, Rhee L, Chen EY, Van Tilburg A: Intron-exon structure of the human transforming growth factor-β precursor gene. Nucleic Acids Res 15:3188-3189, 1987.
27. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T: Molecular structure of the human cytoplasmic β-actin gene: Interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82:6133-6137, 1985.
28. Larsson L-I, Hougaard DM: "Nonradioactive In Situ mRNA Hybridization Using Synthetic Oligonucleotides: Principles, Combination With Immunocytochemistry and Quantitation." New York: Neuroscience Protocols, Elsevier Science Publishers B. V., 1993.
29. Taylor CR, Shi S-R, Chaiwun B, Young L, Imam SR, Cote RJ: Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections. Hum Pathol 25: 263-270, 1994.
30. Flanders KC, Thompson NL, Cissel DS, Van Obberghen-Schilling E, Baker CC, Kass ME, Ellingsworth LR, Roberts AB, Sporn MB: Transforming growth factor-β1: Histochemical localization with antibodies to different epitopes. J Cell Biol 108:653-659, 1989.
31. Kim S-J, Park K, Koeller D, Kim KY, Wakefield LM, Sporn MB, Roberts AB: Post-transcriptional regulation of transforming growth factor β-1 gene. J Biol Chem 19:13702-13707, 1992.
32. Ito M, Yasui W, Nakayama H, Yokozaki H, Ito H, Tahara E: Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas. Jpn J Cancer Res 83:86-92, 1992.
33. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKW: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338, 1995.
34. Attisano L, Wrana JL, Lopes-Casilas F, Massague J: TGF-β receptors and actions. Biochim Biophys Acta 1222:71-80, 1994.
35. Lin HY, Moustakas A: TGF-β receptors: Structure and function. Cell Mol Biol 40:337-349, 1994.
36. Kyprianou N, Isaacs JT: Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgens. Endocrinology 123:2124-2131, 1988.
37. Shain SA, Lin AL, Koger JD, Karaganis AG: Rat prostate cancer cells contain functional receptors for transforming growth factor-β. Endocrinology 126:818-825, 1990.
38. Fine A, Goldstein RH: The effect of transforming growth factor β on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem 262:3897-3902, 1987.
39. Ignotz RA, Massague J: Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345, 1986.